A Rare Second Chance

567 Calls and Counting…

Dear Registrant,  Nick Christ, Director of Member Services here.  Life doesn’t always offer second chances…  But when I saw that my team had conducted 567 customer service calls this week setting new members up with their new TradeSmithGPT logins for Predictive Alpha Options…  I told our CEO Keith Kaplan we have no choice but to open the doors again for one more day. So if you want to lock in tens of thousands of dollars in value, and save thousands in subscription fees, then please call us between 9 AM and 5 PM ET today at (888) 394-0108. When you call us, we will answer any questions you have about the new AI software… the trading strategy… what to expect from this research service… and the Satisfaction Guarantee. You’ll get a one-on-one appointment by simply calling (888) 394-0108. Or book a private appointment here — simply choose your time and we’ll call you. OR, for fastest service… Click here to check out all the details on our secure order form to get started now. Just remember: This really is your last chance to save thousands in subscription fees… And lock in more than $12,000 in value… At midnight this offer will be gone for good! I know our lines have been busy for a week straight now and it may have been nearly impossible for you to reach us regarding our brand-new AI GPT software.  So while we’ve already shut down the offer that Keith Kaplan made during The World Premiere: TradeSmithGPT…  Because you signed up for the event…  You have a rare second chance to still get in.  Remember, when you give us a call, you’re not agreeing to buy.  You’re only agreeing to talk with us and learn more about the special limited-time offer expiring at midnight TONIGHT. I’d hate for you to look back and wish you had gotten into our special offer, just because we didn’t answer all of your questions. You can secure a private appointment anytime from 9 AM to 5 PM ET: Call (888) 394-0108 Or Book a Private Appointment Here. Simply choose a time and we’ll call you:  Now’s your last chance. See here BEFORE midnight <<< When you join Predictive Alpha Options today you’ll immediately receive…  60% OFF 1 year of Predictive Alpha Options ($5,000 value) 1 FREE year of access to the Predictive Alpha Options AI Software & TradeSmithGPT Tool ($5,000 value) BONUS: TradeSmithGPT: 3 Trades Poised For Massive Gains in the Coming Days BONUS: AI Options Investing Guide BONUS: Options 101 Masterclass BONUS: The TrendSync Basket ($1,000 value) BONUS: 1 FREE year of Alpha Signals service ($3,000 value) And more!  Don’t let this opportunity pass you by. This is your last chance.  Give us a call now at (888) 394-0108 or click the link below... Link expires @ MIDNIGHT. Nick Christ Director of Member Services, TradeSmith   You are receiving this message because you signed up to receive exclusive offers about this event from TradeSmith. To unsubscribe or change your email preferences, please click here. © 2025 TradeSmith, LLC. All Rights Reserved. 1125 N. Charles Street, Baltimore, MD 21201 Terms of Use  |  Privacy Policy  |  Unsubscribe

"BNZI" Expands Enterprise Footprint!

Banzai International has expanded its agreement with RBC Capital Markets, providing an enterprise license for its OpenReel video creation platform. This move strengthens BNZI's position in the financial sector and supports its broader enterprise growth strategy.‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­‌   ­

*Sponsored By TD Media. Please see disclosures below.   "BNZI" Strengthens OpenReel Adoption  ­ Folks,   Banzai International (BNZI) has deepened its relationship with RBC Capital Markets through an expanded agreement.    BNZI's OpenReel platform will now be licensed at the enterprise level for RBC's Wealth Marketing Division, marking a notable step forward from its prior engagement with the company.   According to CEO Joe Davy, this expansion not only doubles Banzai's engagement within RBC but also reinforces its strategic focus on enterprise growth.    OpenReel, which enables the remote creation of branded, professional-grade videos, is gaining traction in the financial sector.    This deal highlights the growing importance of video in financial marketing strategies.    It also positions Banzai as a go-to partner for institutions seeking streamlined, consistent content creation across large teams.   Anyways... That's all for now!   Until Next Time, -Damian P.S. Want our text alerts? Text "ZIPTRADER" to 1-(855)-228-1598 to sign up!  (standard carrier data/text rates apply) *Sponsored By TD Media. Please see disclosures below.  ZIPTRADER LLC 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA You've received it because you've subscribed to our newsletter or are a member of ZipTraderU. This email was sent to stevenmagallanes520.nims@blogger.com *SPONSORED CONTENT* ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.  ZipTrader has been compensated fifteen thousand USD by ACH Bank Transfer by TD Media LLC, who received funds from Sideways Frequency LLC, to distribute media via email and SMS for Banzai International, Inc. (BNZI) from July 1, 2025 to July 2, 2025. ZipTrader has been compensated seventeen thousand five hundred USD by ACH Bank Transfer by TD Media LLC dba Lifewater Media to distribute media via email and SMS for Banzai International, Inc. (BNZI) from April 6, 2025 to April 7, 2025. ZipTrader has been compensated four thousand five hundred USD by ACH Bank Transfer by TD Media LLC dba Lifewater Media to distribute media via email and SMS for Banzai International, Inc. (BNZI) from March 4, 2025 to March 5, 2025. The reader should assume that paying parties, clients of paying parties, and third parties may own shares and may sell shares during or after this campaign, which could negatively impact the stock price. ZipTrader may receive additional campaigns in the future by TD Media LLC to distribute media for Banzai International, Inc. (BNZI). As a result of this advertisement and other marketing efforts, ZipTrader may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of ZipTrader do not hold a position in Banzai International, Inc. (BNZI). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Banzai International, Inc. (BNZI), increased trading volume, and possibly an increased share price of Banzai International, Inc. (BNZI), which may or may not be temporary and decrease once the marketing arrangement has ended. BY READING THIS EMAIL & ALL ZIPTRADER CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZIPTRADER LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk. Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. TRADING IS RISKY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered here if you are not prepared with the reality that most fail. We reserve the right to have affiliate relationships with advertisers/sponsors. See Full Terms of Service.See Our Advertisement/Sponsored Stock Disclaimer. View in browser | Unsubscribe

He found a 1,007% gain as stocks crumbled

Dear Reader, When Netflix stock took a huge plunge, Jeff Clark celebrated. His “Crossfire” play delivered an incredible 1,007% return. He didn’t buy the stock. He had no insider knowledge.  He just used a simple strategy to repeatedly turn stock downturns into massive paydays. In his urgent briefing, Jeff reveals exactly how you can apply this strategy immediately: How $1,000 became $10,070 How you can do it again and again, during any market sell-off Why you must learn this strategy now This is your chance to profit no matter what direction stocks move next. But hurry. Access to this exclusive presentation ends soon. Watch Jeff’s video walkthrough now right here. Regards, Rachel Bodden  Senior Managing Editor, TradeSmith To ensure that you continue to receive marketing emails from TradeSmith, please add info@exct.tradesmith.com to your address book. If you no longer want to receive marketing emails from TradeSmith, please click here to unsubscribe. If you have any questions, please don't hesitate to contact Customer Service at support@tradesmith.com or by calling 1-866-385-2076. © 2025 TradeSmith, LLC. All Rights Reserved. 1125 N. Charles Street, Baltimore, MD 21201 Terms of Use  |  Privacy Policy  |  Unsubscribe

Why Volatility Keeps Coming Back — And How I Trade It

Dear Reader, You’ve probably noticed something about the markets. They don’t stay calm for long. One week it’s inflation. The next its tech stocks crashing. Or some new political announcement, tariffs, or a Fed decision. The reason doesn’t really matter. The one thing you can always count on is volatility. You can see it right on the VIX chart — the market’s fear gauge. It spikes. It dips. But it always comes back. In fact, those big spikes in the VIX? That’s when I make my biggest trades… and when you should too. Unlike most investors, I don’t fear volatility. I hunt it. I use a straightforward strategy built to thrive in times like this. It’s a three-step method that turns those big market swings into fast paydays. It doesn’t matter whether the market’s up or down… It only matters that it’s moving… And you can count on that. The best part? You don’t need to spend hours watching charts or guessing where the market’s headed. I’ll show you exactly how I do it — step by step — in this free video. Click here to see how it works. If you’re tired of worrying about what the Fed will do next… Or panicking when stocks crash… There’s a better way. It only takes a few minutes a day. Watch the free video now and see why volatility is not your enemy — it’s your greatest opportunity. Click here to watch now. Jeff Clark Senior Analyst, TradeSmith © TradeSmith, LLC. All Rights Reserved. 1125 N. Charles Street, Baltimore, MD 21201 To ensure our emails continue reaching your inbox, please add our email address to your address book. No longer wish to receive special offers from us? Click here for options.

Abby Schwartz still remembers how the doctor tried to comfort her... He had just told her that her 21-month-old daughter, Sammie, had cystic fibrosis ("CF"). It's a crippling condition caused by a rare genetic mutation.

Innovation Is Still Improving Lives By Marc Chaikin, founder, Chaikin Analytics Abby Schwartz still remembers how the doctor tried to comfort her... He had just told her that her 21-month-old daughter, Sammie, had cystic fibrosis ("CF"). It's a crippling condition caused by a rare genetic mutation. The doctor tried to soften the blow. As he said... The good news is the life expectancy for someone with CF is almost 31 years. Schwartz and her husband sat quietly. She was 31 at the time. It's a nightmare scenario for every parent. And the heartbreak must have been excruciating. CF is an awful condition to deal with. It causes thick mucus to build up in organs – including the lungs, pancreas, and intestines. Patients typically have difficulty breathing. And they get frequent infections like pneumonia and bronchitis. Schwartz spent years teaching her daughter to follow a strict regimen of more than a dozen different drugs. For example, CF interferes with the body's ability to get nutrients from food. So Sammie had to take special capsules full of pancreatic enzymes before every meal. Twice a day, Sammie needed to use a nebulizer device to thin the mucus in her lungs. She also wore a special vibrating vest to loosen the mucus. Schwartz would help by pounding on her daughter's back while she watched her favorite TV shows. It was an exhausting routine for Schwartz... Recommended Links: July 7 Could Ignite a Financial Nightmare One man warned about a black-swan event before COVID-19 happened... Two years later, he called the 2023 bank run... And this year, he predicted the 2025 crash 13 days before it unfolded. Now, he has a chilling warning for the U.S. brokerage system on July 7. By tomorrow, click here to learn more. Changes Ahead for Social Security? According to a Boston-based institutional financial-research firm serving clients like Goldman Sachs, JPMorgan Chase, and BlackRock, "The way income will be calculated for Social Security could soon change forever." Today, the firm is sounding the alarm on huge changes ahead. It adds, "Sources confirm: AI is already inside the Social Security Administration, with a full federal action plan due this summer." Click here to see how it could impact your money. Managing CF Treatments Took a Big Emotional Toll She handled daily checklists of filling prescriptions and scheduling treatments – including blood tests, chest X-rays, and "sputum cultures" to check for lung infections. Early on, she joined a network of parents who also had children with CF. It was great for learning how to manage her daughter's disease. But it also came with a downside... Someone in the group would eventually lose their child. Sometimes, they were well into adulthood. Other times, they were much younger. It's upsetting to think about. Schwartz would go to the funeral and be supportive. She wrote about how it felt sitting beside two other mothers of children with CF... We were the lucky ones whose daughters were still alive. Silent, we stared ahead, clutching one another's hands. I envisioned the three of us on a rowboat, in the middle of a storm-tossed ocean, sharks circling – waiting to tear us apart. Meanwhile, Schwartz tried to avoid thinking about how long her daughter would survive with CF. Sammie had a close call after her junior year of high school. She developed a bad lung infection. It required a long hospital stay, antibiotics, and a special airway-clearance therapy. Schwartz noticed that her daughter's lung function never fully recovered after that infection. It's an example of why CF is a "degenerative" disease – it slowly damages the lungs and other organs. In 2018, Sammie was accepted into a clinical trial for a promising new CF drug... A Breakthrough in Treatment Early results showed that it worked for most CF patients. That made it a major improvement over earlier treatments. Sammie took the drug for a few weeks. But she didn't notice any difference. However, only half of the patients in clinical trials get the drug. The other half gets a placebo that does nothing. That's how researchers test how well a drug works. They measure the difference between the two groups. When the trials moved to the next stage, Sammie received the "real" drug. The effects were almost immediate. She started coughing up mucus – a sign her lungs were clearing. The worst symptoms improved dramatically over the next few weeks... Sammie could breathe easily. Her chronic cough – which she had since middle school – disappeared completely. And she was able to stop taking insulin. The drug is called Trikafta. For CF patients, it's a literal lifesaver. And it's also a huge deal for Schwartz. As she said in the Washington Post... I was an emotional mess the week Trikafta was approved. It felt like I'd been holding my breath for 20 years and could finally exhale. Today, Sammie – and thousands of other CF patients – can look forward to living longer, more comfortable lives thanks to Trikafta. It's also a game changer for parents. In the Washington Post, Schwartz explained how her relationship with her daughter has changed... She no longer needs me to be her caretaker. I can just be her mom. Trikafta is one of the biggest success stories in modern medicine. It's another example of humanity's incredible progress. And it shows the power of biotech to change lives. Folks, sometimes it seems like negative news has taken over the world. Every time we turn on the TV, we see something terrible. The reality is that humanity is still making progress. Innovation is still improving lives. And it's still creating investment opportunities. Sure, the biotech sector comes with plenty of risk. But the potential to change lives – and for big investment gains – is massive. In fact, the Power Gauge currently says the biotech industry is strong... Out of 532 stocks in the industry with ratings, 191 are "bullish" or better. And 69 are rated "bearish" or worse. So it's worth paying attention to biotech right now. Good investing, Marc Chaikin   Editor's note: As you've likely heard by now, Marc has recently been pounding the table on a different kind of opportunity. And it all has to do with the biggest breakthrough in the history of our firm... In short, it's the most lucrative new investment vehicle Marc has discovered in 50 years on Wall Street. It represents fewer than 3% of public companies. And Marc predicts these incredibly rare vehicles will be the best place to put your money for the greatest potential gains this year. Get the full story here. Market View Major Indexes and Notable Sectors     # Hld:     Bullish     Neutral     Bearish Dow 30 +0.96% 11 12 7 S&P 500 -0.03% 126 268 106 Nasdaq -0.84% 28 56 17 Small Caps +1.03% 619 909 351 Bonds -0.12% Materials +2.59% 5 10 11 — According to the Chaikin Power Bar, Small Cap stocks and Large Cap stocks are somewhat Bullish. Major indexes are all bullish. *  *  *  * Sector Tracker Sector movement over the last 5 days Materials +2.76% Communication +2.4% Health Care +2.19% Financial +2.09% Industrials +2.03% Information Technology +1.51% Consumer Discretionary +1.24% Consumer Staples +0.8% Energy +0.65% Utilities +0.43% Real Estate -1.33% *  *  *  * Industry Focus Insurance Services 13 32 8 Over the past 6 months, the Insurance subsector (KIE) has outperformed the S&P 500 by +0.57%. Its Power Bar ratio, which measures future potential, is Strong, with more Bullish than Bearish stocks. It is currently ranked #13 of 21 subsectors. Top Stocks MCY Mercury General Corp OSCR Oscar Health, Inc. GL Globe Life Inc. *  *  *  * Top Movers Gainers LVS +8.89% WYNN +8.85% BLDR +8.76% PKG +7.59% MGM +7.27% Losers WMB -6.51% AXON -6.35% TSLA -5.34% HWM -5.32% EXE -4.92% *  *  *  * Earnings Report Reporting Today Rating Before Open After Close No earnings reporting today. Earnings Surprises STZ Constellation Brands, Inc. Q1 $3.22 Missed by $-0.07 MSM MSC Industrial Direct Co., Inc. Q3 $1.08 Beat by $0.05 *  *  *  * You have received this e-mail as part of your subscription to PowerFeed. If you no longer want to receive e-mails from PowerFeed, click here. You're receiving this e-mail at STEVENMAGALLANES520.NIMS@BLOGGER.COM. For questions about your account or to speak with customer service, call +1 (877) 697-6783 (U.S.), 9 a.m. - 5 p.m. Eastern time or e-mail info@chaikinanalytics.com. Please note: The law prohibits us from giving personalized financial advice. © 2025 Chaikin Analytics, LLC. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Chaikin Analytics, LLC. 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. www.chaikinanalytics.com. Any brokers mentioned constitute a partial list of available brokers and is for your information only. Chaikin Analytics, LLC, does not recommend or endorse any brokers, dealers, or investment advisors. Chaikin Analytics forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Chaikin Analytics, LLC (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation. This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.